XLO
Xilio Therapeutics, Inc.Company with tickers: XLO
CIK
1840233
CUSIP
98422T100
Shares Outstanding
5,782,511
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-26 | Shannon James Samuel | Director | Buy | 5,000 |
| 2026-01-02 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | Sell | 1,826 |
| 2026-01-02 | Frankenfield Christopher James | Chief Financial Officer | Sell | 7,030 |
| 2026-01-01 | Luptakova Katarina | CHIEF MEDICAL OFFICER | Convert | 16,625 |
| 2026-01-01 | Luptakova Katarina | CHIEF MEDICAL OFFICER | Convert | 16,625 |
| 2026-01-01 | Russo Rene | Director | Convert | 44,250 |
| 2026-01-01 | Russo Rene | Director | Convert | 44,250 |
| 2026-01-01 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | Convert | 5,000 |
| 2026-01-01 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | Convert | 5,000 |
| 2026-01-01 | Frankenfield Christopher James | Chief Financial Officer | Convert | 19,375 |
| 2026-01-01 | Frankenfield Christopher James | Chief Financial Officer | Convert | 19,375 |
| 2025-12-31 | Luptakova Katarina | CHIEF MEDICAL OFFICER | Award | 451,885 |
| 2025-12-31 | Russo Rene | Director | Award | 1,500,258 |
| 2025-12-31 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | Award | 95,221 |
| 2025-12-31 | Frankenfield Christopher James | Chief Financial Officer | Award | 668,789 |
| 2025-11-21 | Frankenfield Christopher James | Chief Financial Officer | Other | 155,090 |
| 2025-11-21 | Frankenfield Christopher James | Chief Financial Officer | Award | 925,000 |
| 2025-11-21 | Russo Rene | Director | Other | 239,703 |
| 2025-11-21 | Russo Rene | Director | Award | 2,075,000 |
| 2025-11-21 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | Other | 55,000 |
| 2025-11-21 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | Award | 131,700 |
| 2025-11-21 | Luptakova Katarina | CHIEF MEDICAL OFFICER | Award | 625,000 |
| 2025-11-21 | Luptakova Katarina | CHIEF MEDICAL OFFICER | Other | 44,210 |
| 2025-06-17 | Shannon James Samuel | Director | Buy | 25,000 |
| 2025-06-16 | Russo Rene | Director | Buy | 36,289 |
| 2025-06-16 | Shannon James Samuel | Director | Buy | 45,000 |
| 2025-06-11 | ROSS ROBERT W. | Director | Award | 31,000 |
| 2025-06-11 | Brennan Aoife | Director, President and CEO | Award | 31,000 |
| 2025-06-11 | Bonstein Sara | Chief Financial Officer | Award | 31,000 |
| 2025-06-11 | Clancy Paul J | Director | Award | 31,000 |
| 2025-06-11 | Curran Daniel J. | Director | Award | 31,000 |
| 2025-06-11 | Xu Yuan | Director | Award | 31,000 |
| 2025-06-11 | Shannon James Samuel | Director | Award | 31,000 |
| 2025-06-11 | Rossi Christina | Director | Award | 31,000 |
| 2025-06-10 | Bello Akintunde Olatokumbo | Director | Award | 62,000 |
| 2025-06-10 | Bello Akintunde Olatokumbo | Director | Other | 0 |
| 2025-04-15 | Frankenfield Christopher James | Chief Financial Officer | Award | 75,000 |
| 2025-04-15 | Russo Rene | Director | Award | 190,000 |
| 2025-01-02 | Frankenfield Christopher James | Chief Financial Officer | Sell | 6,954 |
| 2025-01-02 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | Sell | 1,803 |
| 2025-01-01 | Luptakova Katarina | CHIEF MEDICAL OFFICER | Convert | 16,625 |
| 2025-01-01 | Luptakova Katarina | CHIEF MEDICAL OFFICER | Convert | 16,625 |
| 2025-01-01 | Luptakova Katarina | CHIEF MEDICAL OFFICER | Award | 200,000 |
| 2025-01-01 | Frankenfield Christopher James | Chief Financial Officer | Convert | 19,375 |
| 2025-01-01 | Frankenfield Christopher James | Chief Financial Officer | Convert | 19,375 |
| 2025-01-01 | Frankenfield Christopher James | Chief Financial Officer | Award | 251,000 |
| 2025-01-01 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | Award | 60,000 |
| 2025-01-01 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | Convert | 5,000 |
| 2025-01-01 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | Convert | 5,000 |
| 2025-01-01 | Russo Rene | Director | Convert | 44,250 |
| 2025-01-01 | Russo Rene | Director | Award | 638,000 |
| 2025-01-01 | Russo Rene | Director | Convert | 44,250 |
| 2024-10-01 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | Award | 26,000 |
| 2024-08-03 | Frankenfield Christopher James | Chief Financial Officer | Award | 52,000 |
| 2024-06-14 | Xu Yuan | Director | Award | 25,000 |
| 2024-06-14 | Bonstein Sara | Chief Financial Officer | Award | 25,000 |
| 2024-06-14 | ROSS ROBERT W. | Director | Award | 25,000 |
| 2024-06-14 | Rossi Christina | Director | Award | 25,000 |
| 2024-06-14 | Clancy Paul J | Director | Award | 25,000 |
| 2024-06-14 | Curran Daniel J. | Director | Award | 25,000 |
| 2024-06-13 | Shannon James Samuel | Director | Award | 50,000 |
| 2024-06-13 | Brennan Aoife | Director, President and CEO | Award | 50,000 |
| 2024-06-13 | Shannon James Samuel | Director | Other | 0 |
| 2024-06-13 | Brennan Aoife | Director, President and CEO | Other | 0 |
| 2024-06-07 | Chudnovsky Yekaterina | Director, 10% Owner | Other | 7,000,000 |
| 2024-05-01 | Luptakova Katarina | CHIEF MEDICAL OFFICER | Award | 59,333 |
| 2024-05-01 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | Award | 20,000 |
| 2024-05-01 | Frankenfield Christopher James | Chief Financial Officer | Award | 208,000 |
| 2024-05-01 | Russo Rene | Director | Award | 474,000 |
| 2024-02-08 | Atlas Venture Fund XI, L.P. | 10% Owner | Sell | 733 |
| 2024-01-12 | Atlas Venture Fund XI, L.P. | 10% Owner | Sell | 1,540 |
| 2024-01-11 | Atlas Venture Fund XI, L.P. | 10% Owner | Sell | 1,566 |
| 2024-01-01 | Frankenfield Christopher James | Chief Financial Officer | Award | 77,500 |
| 2024-01-01 | Luptakova Katarina | CHIEF MEDICAL OFFICER | Award | 66,500 |
| 2024-01-01 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | Award | 20,000 |
| 2024-01-01 | Russo Rene | Director | Award | 177,000 |
| 2023-09-05 | Luptakova Katarina | CHIEF MEDICAL OFFICER | Award | 106,000 |
| 2023-09-05 | Luptakova Katarina | CHIEF MEDICAL OFFICER | Other | 0 |
| 2023-08-16 | Russo Rene | Director | Award | 700,000 |
| 2023-08-16 | Frankenfield Christopher James | Chief Financial Officer | Award | 300,000 |
| 2023-08-16 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | Award | 25,000 |
| 2023-08-16 | Huber Martin H. Jr. | Director | Award | 136,500 |
| 2023-08-03 | Frankenfield Christopher James | Chief Financial Officer | Award | 150,000 |
| 2023-08-03 | Frankenfield Christopher James | Chief Financial Officer | Other | 0 |
| 2023-06-12 | Bonstein Sara | Chief Financial Officer | Award | 13,200 |
| 2023-06-12 | Rossi Christina | Director | Award | 13,200 |
| 2023-06-12 | Clancy Paul J | Director | Award | 13,200 |
| 2023-06-12 | ROSS ROBERT W. | Director | Award | 13,200 |
| 2023-06-12 | Heyman Tomas J. | Director | Award | 13,200 |
| 2023-06-12 | Xu Yuan | Director | Award | 13,200 |
| 2023-04-01 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | Award | 55,000 |
| 2023-03-30 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | Other | 0 |
| 2023-01-01 | Russo Rene | Director | Award | 350,000 |
| 2023-01-01 | Huber Martin H. Jr. | Director | Award | 136,500 |
| 2023-01-01 | English Edward C | PRINCIPAL ACCOUNTING OFFICER | Award | 24,000 |
| 2022-11-09 | English Edward C | PRINCIPAL ACCOUNTING OFFICER | Other | 0 |
| 2022-11-09 | English Edward C | PRINCIPAL ACCOUNTING OFFICER | Other | 6,002 |
| 2022-09-15 | Heyman Tomas J. | Director | Award | 26,400 |
| 2022-09-15 | Heyman Tomas J. | Director | Other | 0 |
| 2022-06-15 | Huber Martin H. Jr. | Director | Award | 20,000 |